BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis
BIT:1BAX - Euronext Milan - US0718131099 - Common Stock - Currency: EUR
Overall 1BAX gets a fundamental rating of 3 out of 10. We evaluated 1BAX against 64 industry peers in the Health Care Equipment & Supplies industry. 1BAX has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
1BAX had positive earnings in the past year.
In the past year 1BAX had a positive cash flow from operations.
In multiple years 1BAX reported negative net income over the last 5 years.
1BAX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1BAX's Return On Assets of -2.52% is in line compared to the rest of the industry. 1BAX outperforms 40.35% of its industry peers.
1BAX's Return On Equity of -9.32% is in line compared to the rest of the industry. 1BAX outperforms 40.35% of its industry peers.
1BAX's Return On Invested Capital of 3.45% is in line compared to the rest of the industry. 1BAX outperforms 49.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1BAX is significantly below the industry average of 8.65%.
The 3 year average ROIC (3.20%) for 1BAX is below the current ROIC(3.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROIC | 3.45% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1.3 Margins
1BAX's Operating Margin of 7.67% is in line compared to the rest of the industry. 1BAX outperforms 56.14% of its industry peers.
1BAX's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 38.01%, 1BAX is not doing good in the industry: 71.93% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1BAX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% |
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BAX is destroying value.
Compared to 1 year ago, 1BAX has more shares outstanding
The number of shares outstanding for 1BAX has been increased compared to 5 years ago.
The debt/assets ratio for 1BAX is higher compared to a year ago.
2.2 Solvency
1BAX has an Altman-Z score of 2.10. This is not the best score and indicates that 1BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1BAX (2.10) is comparable to the rest of the industry.
1BAX has a debt to FCF ratio of 22.91. This is a negative value and a sign of low solvency as 1BAX would need 22.91 years to pay back of all of its debts.
1BAX has a Debt to FCF ratio (22.91) which is comparable to the rest of the industry.
1BAX has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
1BAX's Debt to Equity ratio of 1.79 is on the low side compared to the rest of the industry. 1BAX is outperformed by 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.53
WACC6.49%
2.3 Liquidity
1BAX has a Current Ratio of 1.36. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
1BAX has a Current ratio of 1.36. This is comparable to the rest of the industry: 1BAX outperforms 45.61% of its industry peers.
A Quick Ratio of 1.05 indicates that 1BAX should not have too much problems paying its short term obligations.
1BAX has a Quick ratio (1.05) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
1BAX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.37%.
1BAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.21% yearly.
1BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.21%.
Measured over the past years, 1BAX shows a decrease in Revenue. The Revenue has been decreasing by -1.31% on average per year.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
3.2 Future
The Earnings Per Share is expected to grow by 6.87% on average over the next years.
The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.61, which indicates a correct valuation of 1BAX.
1BAX's Price/Earnings ratio is rather cheap when compared to the industry. 1BAX is cheaper than 89.47% of the companies in the same industry.
1BAX is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.58, the valuation of 1BAX can be described as correct.
Based on the Price/Forward Earnings ratio, 1BAX is valued a bit cheaper than the industry average as 75.44% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, 1BAX is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1BAX is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
1BAX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1BAX is cheaper than 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.59 | ||
| EV/EBITDA | 13.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.17%, 1BAX has a reasonable but not impressive dividend return.
1BAX's Dividend Yield is rather good when compared to the industry average which is at 2.33. 1BAX pays more dividend than 80.70% of the companies in the same industry.
1BAX's Dividend Yield is comparable with the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
On average, the dividend of 1BAX grows each year by 6.89%, which is quite nice.
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of 1BAX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
BIT:1BAX (3/26/2025, 7:00:00 PM)
30.905
+0.18 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap15.85B
Analysts68.18
Price Target35.44 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.61 | ||
| Fwd PE | 13.58 | ||
| P/S | 1.36 | ||
| P/FCF | 30.59 | ||
| P/OCF | 17.2 | ||
| P/B | 2.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.5 |
EPS(TTM)2.45
EY7.93%
EPS(NY)2.28
Fwd EY7.36%
FCF(TTM)1.01
FCFY3.27%
OCF(TTM)1.8
OCFY5.81%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| ROCE | 5.12% | ||
| ROIC | 3.45% | ||
| ROICexc | 3.76% | ||
| ROICexgc | 8.07% | ||
| OM | 7.67% | ||
| PM (TTM) | N/A | ||
| GM | 38.01% | ||
| FCFM | 4.46% |
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexcg growth 3Y-30.34%
ROICexcg growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 22.91 | ||
| Debt/EBITDA | 6.3 | ||
| Cap/Depr | 44.73% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 4.42 | ||
| Cash Conversion | 51.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.1 |
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%